Featured Webcast of the month

Keith Oldroyd presents the results of LEADERS-FREE

Watch and listen to our webcast of the month

LEADERS-FREE, a randomised double-blinded trial published in the New England Journal of Medicine (NEJM LEADERS FREE). The trial was designed to assess the combination of a short course (1 month) of DAPT with either the BioFreedom drug coated stent or the Gazelle BMS in patients with a high risk of bleeding.

  • Oral anticoagulant treatment
  • Elderly ≥ 75
  • Anaemia
  • Low platelet count
  • Previous bleeding
  • Co-morbid disease (eg chronic renal failure or cancer)

Here Keith Oldroyd presents the results of LEADERS-FREE and how this may change the way we treat high risk population who often have the most to gain from revascularisation.

Become a member today

And get access to more content like this

Join